Cargando…
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73
Dysregulation of cellular transcription and translation is a fundamental hallmark of cancer. As CDK9 and Mnks play pivotal roles in the regulation of RNA transcription and protein synthesis, respectively, they are important targets for drug development. We herein report the cellular mechanism of a n...
Autores principales: | Lam, Frankie, Abbas, Abdullahi Y., Shao, Hao, Teo, Theodosia, Adams, Julian, Li, Peng, Bradshaw, Tracey D., Fischer, Peter M., Walsby, Elisabeth, Pepper, Chris, Chen, Yi, Ding, Jian, Wang, Shudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202154/ https://www.ncbi.nlm.nih.gov/pubmed/25277198 |
Ejemplares similares
-
CDKI-73 Is a Novel Pharmacological Inhibitor of Rab11 Cargo Delivery and Innate Immune Secretion
por: Sorvina, Alexandra, et al.
Publicado: (2020) -
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine
por: Walsby, Elisabeth, et al.
Publicado: (2013) -
CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity
por: Bonelli, Patrizia, et al.
Publicado: (2014) -
Targeting CDK9 for treatment of colorectal cancer
por: Rahaman, Muhammed H., et al.
Publicado: (2019) -
Liquid Biopsy: A New Tool for Overcoming CDKi Resistance Mechanisms in Luminal Metastatic Breast Cancer
por: González-Conde, Miriam, et al.
Publicado: (2021)